{"id":"https://openalex.org/W3090171308","doi":"https://doi.org/10.4155/fmc-2020-0262","title":"De Novo Design of New Chemical Entities for SARS-CoV-2 Using Artificial Intelligence","display_name":"De Novo Design of New Chemical Entities for SARS-CoV-2 Using Artificial Intelligence","publication_year":2021,"publication_date":"2021-02-16","ids":{"openalex":"https://openalex.org/W3090171308","doi":"https://doi.org/10.4155/fmc-2020-0262","mag":"3090171308","pmid":"https://pubmed.ncbi.nlm.nih.gov/33590764","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7888348"},"language":"en","primary_location":{"id":"doi:10.4155/fmc-2020-0262","doi":"https://doi.org/10.4155/fmc-2020-0262","is_oa":false,"landing_page_url":"https://doi.org/10.4155/fmc-2020-0262","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74966ee301ca717c79a3e/original/de-novo-design-of-new-chemical-entities-nc-es-for-sars-co-v-2-using-artificial-intelligence.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027584199","display_name":"Navneet Bung","orcid":"https://orcid.org/0000-0002-6376-277X","observed_orcids":["https://orcid.org/0000-0002-6376-277X"]},"institutions":[{"id":"https://openalex.org/I55215948","display_name":"Tata Consultancy Services (India)","ror":"https://ror.org/01b9n8m42","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210086519","https://openalex.org/I55215948"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Navneet Bung","raw_affiliation_strings":["TCS Innovation Labs-Hyderabad (Life Sciences Division) , Tata Consultancy Services Limited , Hyderabad 500081 , India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCS Innovation Labs-Hyderabad (Life Sciences Division) , Tata Consultancy Services Limited , Hyderabad 500081 , India","institution_ids":["https://openalex.org/I55215948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102810785","display_name":"Sowmya Ramaswamy Krishnan","orcid":"https://orcid.org/0000-0001-5404-3266","observed_orcids":["https://orcid.org/0000-0001-5404-3266"]},"institutions":[{"id":"https://openalex.org/I55215948","display_name":"Tata Consultancy Services (India)","ror":"https://ror.org/01b9n8m42","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210086519","https://openalex.org/I55215948"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sowmya Ramaswamy Krishnan","raw_affiliation_strings":["TCS Innovation Labs-Hyderabad (Life Sciences Division) , Tata Consultancy Services Limited , Hyderabad 500081 , India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCS Innovation Labs-Hyderabad (Life Sciences Division) , Tata Consultancy Services Limited , Hyderabad 500081 , India","institution_ids":["https://openalex.org/I55215948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018990576","display_name":"Gopalakrishnan Bulusu","orcid":"https://orcid.org/0000-0002-4958-7573","observed_orcids":["https://orcid.org/0000-0002-4958-7573"]},"institutions":[{"id":"https://openalex.org/I55215948","display_name":"Tata Consultancy Services (India)","ror":"https://ror.org/01b9n8m42","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210086519","https://openalex.org/I55215948"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Gopalakrishnan Bulusu","raw_affiliation_strings":["TCS Innovation Labs-Hyderabad (Life Sciences Division) , Tata Consultancy Services Limited , Hyderabad 500081 , India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCS Innovation Labs-Hyderabad (Life Sciences Division) , Tata Consultancy Services Limited , Hyderabad 500081 , India","institution_ids":["https://openalex.org/I55215948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042990614","display_name":"Arijit Roy","orcid":"https://orcid.org/0000-0002-1961-2483","observed_orcids":["https://orcid.org/0000-0002-1961-2483"]},"institutions":[{"id":"https://openalex.org/I55215948","display_name":"Tata Consultancy Services (India)","ror":"https://ror.org/01b9n8m42","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210086519","https://openalex.org/I55215948"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Arijit Roy","raw_affiliation_strings":["Tata Consultancy Services Limited","TCS Innovation Labs-Hyderabad (Life Sciences Division)\rTata Consultancy Services Limited\rHyderabad\r500081\rIndia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tata Consultancy Services Limited","institution_ids":["https://openalex.org/I55215948"]},{"raw_affiliation_string":"TCS Innovation Labs-Hyderabad (Life Sciences Division)\rTata Consultancy Services Limited\rHyderabad\r500081\rIndia","institution_ids":["https://openalex.org/I55215948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5018990576","https://openalex.org/A5042990614"],"corresponding_institution_ids":["https://openalex.org/I55215948"],"apc_list":null,"apc_paid":null,"fwci":6.6056,"has_fulltext":false,"cited_by_count":122,"citation_normalized_percentile":{"value":0.98538338,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"13","issue":"6","first_page":"575","last_page":"585"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11948","display_name":"Machine Learning in Materials Science","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":1.0},{"id":"https://openalex.org/keywords/main-protease","display_name":"main protease","score":0.9440000057220459},{"id":"https://openalex.org/keywords/mpro-inhibitors","display_name":"Mpro inhibitors","score":0.878000020980835},{"id":"https://openalex.org/keywords/de-novo-drug-design","display_name":"de novo drug design","score":0.9559999704360962},{"id":"https://openalex.org/keywords/generative-models","display_name":"generative models","score":0.777999997138977},{"id":"https://openalex.org/keywords/deep-neural-network","display_name":"deep neural network","score":0.7829999923706055},{"id":"https://openalex.org/keywords/transfer-learning","display_name":"transfer learning","score":0.8569999933242798},{"id":"https://openalex.org/keywords/reinforcement-learning","display_name":"reinforcement learning","score":0.9959999918937683},{"id":"https://openalex.org/keywords/virtual-screening","display_name":"virtual screening","score":0.8519999980926514},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.8029999732971191}],"concepts":[{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.6074564456939697},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.5626139640808105},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.4794299006462097},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4415135681629181},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4394959509372711},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.38759729266166687},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3460997939109802},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23818349838256836},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.15542355179786682},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.08852913975715637},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000086782","descriptor_name":"Coronavirus 3C Proteases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000086782","descriptor_name":"Coronavirus 3C Proteases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000086782","descriptor_name":"Coronavirus 3C Proteases","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000093485","descriptor_name":"COVID-19 Drug Treatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001185","descriptor_name":"Artificial Intelligence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.4155/fmc-2020-0262","doi":"https://doi.org/10.4155/fmc-2020-0262","is_oa":false,"landing_page_url":"https://doi.org/10.4155/fmc-2020-0262","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},{"id":"doi:10.26434/chemrxiv.11998347","doi":"https://doi.org/10.26434/chemrxiv.11998347","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.11998347","pdf_url":"https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74966ee301ca717c79a3e/original/de-novo-design-of-new-chemical-entities-nc-es-for-sars-co-v-2-using-artificial-intelligence.pdf","source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"doi:10.26434/chemrxiv.11998347.v1","doi":"https://doi.org/10.26434/chemrxiv.11998347.v1","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.11998347.v1","pdf_url":"https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74925567dfecd6eec4b4c/original/de-novo-design-of-new-chemical-entities-nc-es-for-sars-co-v-2-using-artificial-intelligence.pdf","source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"doi:10.26434/chemrxiv.11998347.v2","doi":"https://doi.org/10.26434/chemrxiv.11998347.v2","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.11998347.v2","pdf_url":null,"source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:7888348","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7888348","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Med Chem","raw_type":"Text"},{"id":"pmid:33590764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33590764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/11998347","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/De_Novo_Design_of_New_Chemical_Entities_NCEs_for_SARS-CoV-2_Using_Artificial_Intelligence/11998347","pdf_url":null,"source":{"id":"https://openalex.org/S7407051385","display_name":"Royal College of Surgeons in Ireland","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142762351","host_organization_name":"Royal College of Surgeons in Ireland","host_organization_lineage":["https://openalex.org/I142762351"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.26434/chemrxiv.11998347","doi":"https://doi.org/10.26434/chemrxiv.11998347","is_oa":true,"landing_page_url":"https://doi.org/10.26434/chemrxiv.11998347","pdf_url":"https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74966ee301ca717c79a3e/original/de-novo-design-of-new-chemical-entities-nc-es-for-sars-co-v-2-using-artificial-intelligence.pdf","source":{"id":"https://openalex.org/S4393918830","display_name":"ChemRxiv","issn_l":"2573-2293","issn":["2573-2293"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3090171308.pdf","grobid_xml":"https://content.openalex.org/works/W3090171308.grobid-xml"},"referenced_works_count":61,"referenced_works":["https://openalex.org/W1505823450","https://openalex.org/W1522301498","https://openalex.org/W1732222442","https://openalex.org/W1924770834","https://openalex.org/W2007539022","https://openalex.org/W2009867031","https://openalex.org/W2034549041","https://openalex.org/W2038702914","https://openalex.org/W2038996946","https://openalex.org/W2043509228","https://openalex.org/W2051992129","https://openalex.org/W2084087750","https://openalex.org/W2088759306","https://openalex.org/W2096541451","https://openalex.org/W2096998441","https://openalex.org/W2108018232","https://openalex.org/W2113364934","https://openalex.org/W2121863487","https://openalex.org/W2134967712","https://openalex.org/W2157331557","https://openalex.org/W2160592148","https://openalex.org/W2165168652","https://openalex.org/W2166867592","https://openalex.org/W2233997862","https://openalex.org/W2284201926","https://openalex.org/W2418882863","https://openalex.org/W2544460047","https://openalex.org/W2564034046","https://openalex.org/W2577596804","https://openalex.org/W2593436234","https://openalex.org/W2609261056","https://openalex.org/W2610148085","https://openalex.org/W2622826845","https://openalex.org/W2752843037","https://openalex.org/W2773987374","https://openalex.org/W2878685838","https://openalex.org/W2887280559","https://openalex.org/W2887447356","https://openalex.org/W2887821507","https://openalex.org/W2899291554","https://openalex.org/W2900694120","https://openalex.org/W2952524552","https://openalex.org/W2963274209","https://openalex.org/W2970971581","https://openalex.org/W2971690404","https://openalex.org/W3000348967","https://openalex.org/W3001118548","https://openalex.org/W3004280078","https://openalex.org/W3007309629","https://openalex.org/W3008047170","https://openalex.org/W3008142620","https://openalex.org/W3008394341","https://openalex.org/W3009912996","https://openalex.org/W3011938510","https://openalex.org/W3012379316","https://openalex.org/W3015608194","https://openalex.org/W3020300207","https://openalex.org/W3102858258","https://openalex.org/W4206579729","https://openalex.org/W4254278957","https://openalex.org/W6885115362"],"related_works":["https://openalex.org/W3121462455","https://openalex.org/W3126326305","https://openalex.org/W3166814632","https://openalex.org/W4296087232","https://openalex.org/W4367627766","https://openalex.org/W4308089091","https://openalex.org/W4381996511","https://openalex.org/W3164054996","https://openalex.org/W4281570112","https://openalex.org/W7132149928"],"abstract_inverted_index":{"Background:":[0],"The":[1,68],"novel":[2,22],"coronavirus":[3],"SARS-CoV-2":[4],"has":[5],"severely":[6],"affected":[7],"the":[8,25,65,82,87,101],"health":[9],"and":[10,52,76,94,117],"economy":[11],"of":[12,59,63],"several":[13],"countries.":[14],"Multiple":[15,90],"studies":[16],"are":[17],"in":[18,29],"progress":[19],"to":[20,79,86],"design":[21,58],"therapeutics":[23],"against":[24,119],"potential":[26,109],"target":[27],"proteins":[28],"SARS-CoV-2,":[30],"including":[31],"3CL":[32,66],"protease,":[33],"an":[34],"essential":[35],"protein":[36],"for":[37,55,100,114],"virus":[38],"replication.":[39],"Materials":[40],"&":[41],"methods:":[42],"In":[43],"this":[44],"study":[45],"we":[46],"employed":[47],"deep":[48],"neural":[49],"network-based":[50],"generative":[51,69],"predictive":[53],"models":[54],"de":[56],"novo":[57],"small":[60],"molecules":[61],"capable":[62],"inhibiting":[64],"protease.":[67],"model":[70],"was":[71],"optimized":[72],"using":[73],"transfer":[74],"learning":[75,78],"reinforcement":[77],"focus":[80],"around":[81],"chemical":[83],"space":[84],"corresponding":[85],"protease":[88],"inhibitors.":[89],"physicochemical":[91],"property":[92],"filters":[93],"virtual":[95],"screening":[96],"score":[97],"were":[98],"used":[99],"final":[102],"screening.":[103],"Conclusion:":[104],"We":[105],"have":[106],"identified":[107],"33":[108],"compounds":[110],"as":[111],"ideal":[112],"candidates":[113],"further":[115],"synthesis":[116],"testing":[118],"SARS-CoV-2.":[120]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":18},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":24},{"year":2021,"cited_by_count":31},{"year":2020,"cited_by_count":15}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-10-08T00:00:00"}